The role of vaccines in preventing bacterial antimicrobial resistance (Q50120750)

25 February 2018

title

The role of vaccines in preventing bacterial antimicrobial resistance (English)

1 reference

25 February 2018

Kathrin U Jansen

1 reference

25 February 2018

author name string

Charles Knirsch

series ordinal

1 reference

25 February 2018

Annaliesa S Anderson

series ordinal

1 reference

25 February 2018

language of work or name

English

0 references

publication date

1 January 2018

1 reference

25 February 2018

published in

Nature Medicine

1 reference

25 February 2018

volume

1 reference

25 February 2018

issue

1 reference

25 February 2018

page(s)

10-19

1 reference

25 February 2018

Antibacterial resistance worldwide: causes, challenges and responses

cites work

1 reference

A European study on the relationship between antimicrobial use and antimicrobial resistance.

21 January 2018

1 reference

Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae

21 January 2018

1 reference

A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail.

21 January 2018

1 reference

Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011

21 January 2018

1 reference

A review of antibiotic use in food animals: perspective, policy, and potential

21 January 2018

1 reference

How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?

21 January 2018

1 reference

The effect of universal influenza immunization on antibiotic prescriptions: an ecological study

21 January 2018

1 reference

The crisis in antibiotic resistance

21 January 2018

1 reference

The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

21 January 2018

1 reference

Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing.

21 January 2018

1 reference

Emergence and global spread of epidemic healthcare-associated Clostridium difficile

21 January 2018

1 reference

Scaling up interventions to achieve global tuberculosis control: progress and new developments

21 January 2018

1 reference

Herd immunity: history, theory, practice

21 January 2018

1 reference

The contribution of vaccination to global health: past, present and future

21 January 2018

1 reference

Effect of a best-practice alert on the rate of influenza vaccination of pregnant women

21 January 2018

1 reference

Varicella Skin Complications in Childhood: A Case Series and a Systematic Review of the Literature.

21 January 2018

1 reference

Antimicrobial resistance in Haemophilus influenzae

21 January 2018

1 reference

The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections

21 January 2018

1 reference

Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme

21 January 2018

1 reference

Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States

21 January 2018

1 reference

Diversity of Ampicillin-Resistance Genes inHaemophilus influenzaein Japan and the United States

21 January 2018

1 reference

Epidemiology, virulence factors and management of the pneumococcus

21 January 2018

1 reference

Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine

21 January 2018

1 reference

Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries

21 January 2018

1 reference

Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study

21 January 2018

1 reference

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands

21 January 2018

1 reference

The role of viral, host, and secondary bacterial factors in influenza pathogenesis

21 January 2018

1 reference

Effectiveness of inactivated influenza vaccine for prevention of otitis media in children

21 January 2018

1 reference

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

21 January 2018

1 reference

Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection

21 January 2018

1 reference

Respiratory viral infection predisposing for bacterial disease: a concise review

21 January 2018

1 reference

Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status

21 January 2018

1 reference

Respiratory syncytial virus infection in elderly and high-risk adults

21 January 2018

1 reference

Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults

21 January 2018

1 reference

Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.

21 January 2018

1 reference

Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design

21 January 2018

1 reference

Protective and Harmful Immunity to RSV Infection.

21 January 2018

1 reference

Respiratory Syncytial Virus Infection: An Illness for All Ages

21 January 2018

1 reference

How do viral infections predispose patients to bacterial infections?

21 January 2018

1 reference

Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines

21 January 2018

1 reference

Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals

21 January 2018

1 reference

Invasive group B streptococcal disease in an orthopaedic unit

21 January 2018

1 reference

Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera

21 January 2018

1 reference

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

21 January 2018

1 reference

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

21 January 2018

1 reference

A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults

21 January 2018

1 reference

Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune Response

21 January 2018

1 reference

Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease

21 January 2018

1 reference

Adherence to surgical care improvement project measures and post-operative surgical site infections

21 January 2018

1 reference

Vaccine development to prevent Staphylococcus aureus surgical-site infections

21 January 2018

1 reference

Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility

21 January 2018

1 reference

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

21 January 2018

1 reference

Intrawound vancomycin powder reduces surgical site infections in posterior cervical fusion

21 January 2018

1 reference

A Retrospective Study on the Protective Effects of Topical Vancomycin in Patients Undergoing Multilevel Spinal Fusion

21 January 2018

1 reference

Staphylococcus aureus antigens and challenges in vaccine development

21 January 2018

1 reference

Staphylococcal vaccines and immunotherapies

21 January 2018

1 reference

A comparison of intestinal microbiota in a population of low-risk infants exposed and not exposed to intrapartum antibiotics: The Baby & Microbiota of the Intestine cohort study protocol

21 January 2018

1 reference

Impact of Prematurity and Perinatal Antibiotics on the Developing Intestinal Microbiota: A Functional Inference Study

21 January 2018

1 reference

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.

21 January 2018

1 reference

Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India

21 January 2018

1 reference

Escherichia coli Harboring mcr-1 and bla CTX-M on a Novel IncF Plasmid: First Report of mcr-1 in the United States

21 January 2018

1 reference

Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field

21 January 2018

1 reference

Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

21 January 2018

1 reference

Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae

21 January 2018

1 reference

Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection

21 January 2018

1 reference

Vaccines against gonorrhea: current status and future challenges.

21 January 2018

1 reference

Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review.

21 January 2018

1 reference

Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine

21 January 2018

1 reference

Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial

21 January 2018

1 reference

Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers

21 January 2018

1 reference

Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study

21 January 2018

1 reference

One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.

21 January 2018

1 reference

A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women

21 January 2018

1 reference

Nonimmunodominant regions are effective as building blocks in a streptococcal fusion protein vaccine.

21 January 2018

1 reference

Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models

21 January 2018

1 reference

Human capital gaps in vaccine development: an issue for global vaccine development and global health

21 January 2018

1 reference

Life-threatening Haemophilus influenzae infections in Scandinavia: a five-country analysis of the incidence and the main clinical and bacteriologic characteristics.

21 January 2018

1 reference

7 January 2021

Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia

1 reference

7 January 2021

Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination

1 reference

7 January 2021

Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines

1 reference

7 January 2021

Risk of primary infection and reinfection with respiratory syncytial virus

1 reference

12 December 2020

Emergence of drug-resistant pneumococcal infections in the United States

1 reference

12 December 2020

Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli

1 reference

12 December 2020

Overview of nosocomial infections caused by gram-negative bacilli

1 reference

12 December 2020

Antiobiotic prophylaxis to prevent surgical site infections

1 reference

12 December 2020

The antibiotic resistance crisis: part 1: causes and threats

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.4465

1 reference

25 February 2018

1 reference

25 February 2018